IUCPQ next Tuesday, with Dr. Christopher Rose from @crchum.bsky.social @umontreal-en.bsky.social to discuss #HepaticEncephalopathy 🧠
IUCPQ next Tuesday, with Dr. Christopher Rose from @crchum.bsky.social @umontreal-en.bsky.social to discuss #HepaticEncephalopathy 🧠
#POSTER TOP-471-YI by Annarein Kerbert et al.
#EASL2026
#HepaticEncephalopathy
#Cirrhosis #Hepatology
@rajivjalan.bsky.social
@europeliver.bsky.social
#POSTER TOP-471-YI by Annarein Kerbert et al.
#EASL2026
#HepaticEncephalopathy
#Cirrhosis #Hepatology
@rajivjalan.bsky.social
@europeliver.bsky.social
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
🔑 we need to do more!
In @varesearch.bsky.social #cirrhosis pts @amcollegegastro.bsky.social
🔑inpt HE adds >4-5 MELD3.0 points for 90D & 6-7 for 1Y mortality
🔑HE needs priority!⤵️
pubmed.ncbi.nlm.nih.gov/39836914/
🔑 we need to do more!
In @varesearch.bsky.social #cirrhosis pts @amcollegegastro.bsky.social
🔑inpt HE adds >4-5 MELD3.0 points for 90D & 6-7 for 1Y mortality
🔑HE needs priority!⤵️
pubmed.ncbi.nlm.nih.gov/39836914/
#HepaticEncephalopathy #LiverDisease #Cirrhosis #Hepatology #VikaasShandily
#HepaticEncephalopathy #LiverDisease #Cirrhosis #Hepatology #VikaasShandily
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Read the full article here: doi.org/10.1016/S187...
#HepaticEncephalopathy #Silibinin #UCP2
Read the full article here: doi.org/10.1016/S187...
#HepaticEncephalopathy #Silibinin #UCP2
#LiverHealth #NeuroCare #Pharma
www.marketresearchfuture.com/reports/over...
#LiverHealth #NeuroCare #Pharma
www.marketresearchfuture.com/reports/over...
🧬 Synthesizes guidelines for acute OHE management in liver cirrhosis.
🩺 Highlights precipitating factors (infections, GI bleeding) & pillars.
📖 Learn More: www.mdpi.com/2673-4389/6/...
#HepaticEncephalopathy #LiverCirrhosis #Guidelines
🧬 Synthesizes guidelines for acute OHE management in liver cirrhosis.
🩺 Highlights precipitating factors (infections, GI bleeding) & pillars.
📖 Learn More: www.mdpi.com/2673-4389/6/...
#HepaticEncephalopathy #LiverCirrhosis #Guidelines
High-dose #GLP1RA therapy is associated with a reduced risk for #HepaticEncephalopathy, supporting its use for patients without #LiverCancer.
High-dose #GLP1RA therapy is associated with a reduced risk for #HepaticEncephalopathy, supporting its use for patients without #LiverCancer.
bpspubs.onlinelibrary.wiley.com/doi/full/10....
bpspubs.onlinelibrary.wiley.com/doi/full/10....
Acharjee, Arup et al.
Paper
Details
#Cerebellum #HepaticEncephalopathy #Proteomics
Acharjee, Arup et al.
Paper
Details
#Cerebellum #HepaticEncephalopathy #Proteomics